Subjects: Medicine, Pharmacy >> Clinical Medicine submitted time 2024-04-25 Cooperative journals: 《中国全科医学》
LI Songjiao
LEI Kangchen
HUANG Hongwen
SONG Jiali
CHANG Yinghui
FAN Xiaonong
LI Li
DU Yuzheng
LIU Jian
CAI Xinru
BIAN Lina
MENG Lina
SONG Qian
SHEN Yan
GE Wenyi
LIU Wei
LI Yibing
JIA Hongbo
GAO Ying
MA Congcong
Abstract： Background Long COVID is a common problem in the recovery period of coronavirus disease（COVID-19）. The prevention and treatment of long COVID has become the focus of the medical fields of COVID-19. It is important to clarify the situation of long COVID in China and find out the follow-up research route，thus providing evidence-based evidence for clinical practice. Objective To explore the characteristics of long COVID in China，aiming to provide references for the follow#2;up research.Methods From January 2023 to August 2023，a self-made survey questionnaire was used to investigate the current situation of long COVID in China. The questionnaire included general information，such as gender and age，treatment expectations，symptoms and signs in acute and recovery period，etc. Results A total of 1001 questionnaires were collected， including 901 people infected with severe acute respiratory syndrome coronavirus 2（SARS-CoV-2），and 585（64.9%） people with long COVID. Binary Logistic regression analysis showed that female（OR=2.000，95% CI=1.477-2.705，P<0.05 ），history of cancer（OR=4.424，95% CI=1.316-14.868，P<0.05 ），and retirement（OR=1.527，95% CI=1.048-2.224， P<0.05）were risk factors for long COVID. Among the 19 symptoms and signs of long COVID，the top three were fatigue（341 people），decrease of memory，comprehension and attention（274 people），and insomnia（217 people）. Low back pain was the leading pain symptom（201 people）. Hair loss was the number one sign to be difficult to self-healing（58.57%）. Acupuncture（55.73%）was the top 1 willingness of treatment，followed by Chinese herbal decoction（53.68%），Chinese traditional patent medicine（47.01 %），Western medicine（24.79%），intravenous drip（12.14%），and hospitalization（11.97%）. Conclusion The incidence of long COVID is relatively high in China. Acupuncture therapy enjoys a widespread favor among patients. It is recommended to carry out targeted research to enhance the clinical evidence for the prevention and treatment of acupuncture therapy. Women，cancer patients，and retired individuals（elderly people）are high-risk groups for long COVID， and low immune function is a common feature among them. It is suggested to establish a database incorporating these populations and conduct cohort studies on the prevention of long COVID through acupuncture. Fatigue，insomnia，and low back pain are more representative symptoms of long COVID，and randomized controlled studies on acupuncture treatment for these three symptoms at first are recommended.
Subjects: Medicine, Pharmacy >> Clinical Medicine submitted time 2022-12-20 Cooperative journals: 《中国全科医学》
Abstract：
Stroke prevention and treatment has been the focus of the global medical community，and the unique advantages of acupuncture for stroke treatment are becoming increasingly prominent，the Chinese guidelines for acute ischemic stroke 2018 recommend acupuncture for acute cerebral infarction patients （grade II recommendation， B evidence）. Case registration is a real-world study，and the consistency of data elements is one of the necessary elements to ensure the plan implementation，efficient data quality，and credible clinical research evidence.In case registration，one of the real-world studies，the consistency of data elements is one of the necessary elements to ensure the implementation of the plan，efficient data quality and credible clinical research evidence. Therefore, the research group developed the data element and definition of this project based on the key research and development project "Research on the Case Registration of acupuncture and moxibustion for the treatment of stroke disease"，in order to optimize the clinical research paradigm of acupuncture and moxibustion for the prevention and treatment of stroke disease.
Hits
Hits
Downloads
Comment